Clinical Trials Sponsored by Genome Medical
Total 56583 results
-
Second GenomeTerminatedNonalcoholic SteatohepatitisUnited States
-
Genome & CompanyNot yet recruitingAdvanced Solid TumorsKorea, Republic of
-
University Medical Center GroningenHuman Genome Sciences Inc.CompletedAdvanced Cervical CancerNetherlands
-
Human Genome Sciences Inc.CompletedNon Small Cell Lung CancerUnited States, Germany, Hungary, Romania
-
Human Genome Sciences Inc.CompletedLupus Erythematosus, SystemicUnited States, Canada
-
Human Genome Sciences Inc.CompletedHIV InfectionsUnited States
-
Human Genome Sciences Inc.CompletedSystemic Lupus ErythematosusUnited States
-
Javelin MedicalGenaeActive, not recruitingStroke | Atrial FibrillationGermany, Spain, Belgium, Czechia, Greece, Hungary, Israel, Poland
-
Human Genome Sciences Inc.CompletedHepatitis C, ChronicCanada, Australia, Israel, Germany, Czech Republic, France, Poland, Romania
-
Human Genome Sciences Inc.CompletedMultiple MyelomaUnited States, Canada, Australia, India
-
Human Genome Sciences Inc.TerminatedRheumatoid ArthritisUnited States, Poland
-
Human Genome Sciences Inc.CompletedCarcinoma, Non-Small-Cell LungUnited States
-
Human Genome Sciences Inc.CompletedLymphoma, Non-HodgkinUnited States
-
Human Genome Sciences Inc.Completed
-
Human Genome Sciences Inc.Withdrawn
-
Human Genome Sciences Inc.CompletedAdvanced Solid TumorsUnited States
-
Human Genome Sciences Inc.CompletedArthritis, RheumatoidUnited States
-
Human Genome Sciences Inc.Completed
-
Human Genome Sciences Inc.TerminatedLymphoid MalignanciesUnited States, United Kingdom
-
HemoShear TherapeuticsPrometrika, LLC; AllStripes Research Inc.; Genome MedicalTerminatedPropionic Acidemia | Methylmalonic AcidemiaUnited States, Canada, United Kingdom
-
Eurofins GenomaEnrolling by invitationEndometriosis | HypofertilityItaly
-
Human Genome Sciences Inc.GlaxoSmithKlineCompletedSystemic Lupus ErythematosusUnited States, Spain, Israel, Netherlands, Canada, Germany, Poland, Romania, Puerto Rico, Costa Rica, Belgium, Slovakia, United Kingdom, Mexico, Italy, Austria, Czech Republic, Sweden, France
-
Human Genome Sciences Inc.GlaxoSmithKlineCompletedSystemic Lupus ErythematosusHong Kong, Taiwan, Korea, Republic of, India, Chile, Argentina, Philippines, Colombia, Brazil, Romania, Australia, Peru, Russian Federation
-
NovartisHuman Genome Sciences Inc.CompletedChronic Hepatitis CTaiwan, Germany, Greece, Italy, Spain, United Kingdom, France, Canada, Australia, India, Poland, Thailand
-
GlaxoSmithKlineHuman Genome Sciences Inc.Completed
-
Human Genome Sciences Inc.NovartisCompletedChronic Hepatitis CKorea, Republic of, United States, Spain, Canada, France, Australia, Israel, Singapore, Thailand, Malaysia, Sweden, Belgium, Germany, Taiwan, Poland, Argentina, India, Puerto Rico, Brazil, Mexico, United Kingdom
-
Human Genome Sciences Inc.NovartisCompletedChronic Hepatitis CUnited States, Spain, Canada, France, Australia, Italy, Israel, Poland, United Kingdom, Germany, Czech Republic, Romania, Austria, India, Puerto Rico
-
Human Genome Sciences Inc.GlaxoSmithKlineTerminatedSystemic Lupus ErythematosusUnited States, Mexico
-
Human Genome Sciences Inc.GlaxoSmithKlineCompleted
-
University of British ColumbiaGenome British Columbia; Genome Canada; Dynacare Laboratories, Inc.RecruitingAdverse Drug Reaction (ADR)Canada
-
CHU de Quebec-Universite LavalLaval University; Genome Canada; Genome Quebec; CERSSPLCompletedShared Decision MakingCanada
-
GlaxoSmithKlineHuman Genome Sciences Inc.CompletedSystemic Lupus ErythematosusKorea, Republic of, Japan
-
GlaxoSmithKlineHuman Genome Sciences Inc.CompletedSystemic Lupus ErythematosusKorea, Republic of, China, Japan
-
Fukushima Medical UniversityHuman Genome Center, Institute of Medical Science, University of TokyoCompleted
-
Fukushima Medical UniversityHuman Genome Center, Institute of Medical Science, University of TokyoUnknown
-
Fukushima Medical UniversityHuman Genome Center, Institute of Medical Science, University of TokyoUnknown
-
Fukushima Medical UniversityHuman Genome Center, Institute of Medical Science, University of TokyoUnknownHepatocellular CarcinomaJapan
-
Iwate Medical UniversityHuman Genome Center, Institute of Medical Science, University of TokyoCompletedRenal Cell Carcinoma
-
Iwate Medical UniversityHuman Genome Center, Institute of Medical Science, University of TokyoCompleted
-
CHU de Quebec-Universite LavalCanadian Institutes of Health Research (CIHR); Laval University; Genome British... and other collaboratorsCompletedTrisomy 21 | Trisomy 18 | Trisomy 13Canada
-
Fukushima Medical UniversityHuman Genome Center, Institute of Medical Science, University of TokyoCompletedNon Small Cell Lung CancerJapan
-
Fukushima Medical UniversityHuman Genome Center, Institute of Medical Science, University of TokyoCompleted
-
Iwate Medical UniversityHuman Genome Center, Institute of Medical Science, University of TokyoUnknown
-
Wakayama Medical UniversityHuman Genome Center, Institute of Medical Science, University of TokyoCompletedPancreatic CancerJapan
-
Iwate Medical UniversityHuman Genome Center, Institute of Medical Science, University of TokyoUnknown
-
Wakayama Medical UniversityHuman Genome Center, Institute of Medical Science, University of TokyoUnknown
-
Genome & CompanyMerck Sharp & Dohme LLCRecruitingBiliary Tract CancerKorea, Republic of
-
PrenomeRecruitingPregnancy Complications | Pregnancy Related | Gestational Diabetes | Risk Reduction | Genetic PredispositionUnited States
-
Genome & CompanyMerck KGaA, Darmstadt, GermanyActive, not recruitingGastric Cancer | Gastroesophageal Junction AdenocarcinomaKorea, Republic of
-
Samsung Medical CenterSamsung Genomic InstituteRecruitingLymphoma, Non-Hodgkin | Lymphoma, HodgkinKorea, Republic of